SPECIAL NOTICE

We are working on upgrading our websites and despite our best endeavours have experienced census type calamities for almost a week now. Our apologies, we hope to have all problems resolved by Monday August 15th.

InvestoGain Australia

SEARCH BY NAME

BROWSE

Browse Australian listed companies0-9A BC DE FGH IJ KL MN OP QR ST UV WX YZ
Browse current Australian managed funds0-9A BCDE FGH IJKL MNOP QRST UVWX YZ

SEARCH BY CODE

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

GENERA BIOSYSTEMS LIMITED (GBI)

Listed on ASX ( $0.14    -0.02    -12.50%)

SHARE PRICES

Former (or subsequent) names

 

Shareholder links

Our website ranking of GBI: rating 2
(2 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Computershare, Yarra Falls, 452 Johnston Street, Abbotsford VIC 3067

Tel : +61 3 9415 4000 or 1300 850 505
Fax : +61 3 9473 2500
RegistryWebsite RegistryEmail

Company details

Address: Small Technologies Cluster, 1 Dalmore Drive, SCORESBY, VIC, AUSTRALIA, 3179
Tel:  (03) 9763 1287 Fax: (03) 9763 2817

Date first listed: 11/06/2008
Company Secretary: Melanie Leydin
Sector: Pharmaceuticals & Biotechnology Industry Group: XHJ
Activities: Developing a series of products with application in human health diagnostics, in particular those areas dealing in women's health
The suspension of trading in the securities of Genera Biosystems Limited (the "Company") will be lifted immediately, following the release of an announcement by the Company. For further information, please refer to the Company's announcement dated 19 December 2014. Security Code: GBI19/12/2014
Following the Company's request for a trading halt announced Wednesday 10th December 2014 and the Company's requests for a voluntary suspension as announced on Friday 12th December 2014, the Company requests an extension to the voluntary suspension of its securities (GBI) pending the release of an announcement to the market regarding a capital raising18/12/2014
The securities of Genera Biosystems Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement by the Company. For further details please refer to the Company's request for suspension. Security Code: GBI11/12/2014
The suspension of trading in the securities of Genera Biosystems Limited (the "Company") will be lifted immediately, following the release of an announcement by the Company. Security Code: GBI17/07/2013
Following the Company's request for a voluntary suspension of its securities announced Wednesday 10th July 2013, the Company requests an extension of the voluntary suspension of its securities (GBI) effective immediately pending the execution of documentation for the issuance of convertible notes. In accordance with ASX Listing Rule 17.2, the Company provides the following information: - The suspension will be until the earlier of the release of the announcement or prior to commencement of trading on Wednesday 17th July 2013. - The Company is not aware of any reason why its suspension should not be granted. - The Company is not aware of any further information which is required to inform the market of the voluntary suspension.15/07/2013
The securities of Genera Biosystems Limited (the "Company") will be suspended from quotation immediately, at the request of the Company, pending the release of an announcement. Security Code: GBI10/07/2013
listed entity carried for record purposes only11/06/2008

ASX Announcements (courtesy of ASX)

 

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    Posting your comments. Please wait...


    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    06/06/2017Richard Hannebery58,888 $0.154$9,055
    23/05/2017Richard Hannebery75,000 $0.155$11,625
    19/05/2017Richard Hannebery75,000 $0.167$12,500
    02/05/2017Richard Hannebery13,252 $0.165$2,187
    21/04/2017Richard Hannebery36,281 $0.180$6,531

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    Lou PanaccioExecutive Chairman25/11/2010
    Richard HanneberyCEO14/05/2013
    Jim KalokerinosNon Exec Director25/11/2010
    David SymonsNon Exec Director14/08/2008
    Karl PoetterExecutive Director25/09/2007

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Tony PantherCFO01/12/200931/12/2012

    Date of first appointment, title may have changed.